Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
Yanshan Huang
Yanshan Huang

General Manager




 DOER Biologics

 Huang got M.D at Zhejiang Universtiy and has more than 20 years experiences on biopharmaceuticals. He had been as CSO in Hangzhou Jiuyuan Gene Engineering co., LTD, during which he was responsible for getting two biosimilar market licenses (include the first G-CSF in China) and a clinic trial permission license for an innovative recombinant protein drug. Since 2008, Dr. Huang was a co-founder of T-mab Biopharma and responsible for the development of T-mab’s therapeutic antibody and protein projects. In T-Mab, he had set up two technology platforms -- the long-acting recombinant protein drugs and therapeutic monoclonal antibodies, and developed 3 innovative biological drugs and 1 biosimilars with 30M RMB shareholder investment, and all are in clinical trials in China. In 2015, T-Mab was acquired by a domestic big pharma in near 300M RMB. After that, Dr. Huang found Doer Biologics in Hangzhou in 2015, which focus in developing biobetterand "best-in-class" biodrugs with creative long-acting biodrug platform and innovative multi-domain technology.